Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
32 hedge funds and large institutions have $4.35M invested in Sophiris Bio, Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
28% more funds holding
Funds holding: 25 → 32 (+7)
21% more capital invested
Capital invested by funds: $3.61M → $4.35M (+$742K)
95% less call options, than puts
Call options by funds: $7K | Put options by funds: $130K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$435K |
| 2 |
Goldman Sachs
New York
|
+$299K |
| 3 |
VF
Virtu Financial
New York
|
+$294K |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$82.8K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$52.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$605K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$32.9K |
| 3 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$32K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$23K |
| 5 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
-$21K |
SPHS Hedge Fund Activity: Q4 2017 in Review
32 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2017, worth a combined $4.35M — up 21% from $3.61M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SPHS positions and 3 closed out — a net gain of 7 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $435K. The largest seller was Sabby Management, cutting an estimated $605K.
- 32 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2017, up from 25 in Q3 2017.
- Funds reported $4.35M of Sophiris Bio, Inc. stock for Q4 2017, up 21% quarter-over-quarter.
- 10 funds opened new Sophiris Bio, Inc. positions in Q4 2017 and 3 closed out, a net change of +7 holders.
- The largest Sophiris Bio, Inc. buyer in Q4 2017 was Millennium Management, an estimated $435K added.
- The largest Sophiris Bio, Inc. seller in Q4 2017 was Sabby Management, an estimated $605K sold.
Based on aggregated 13F filings for Q4 2017.